cordarone 200 mg
sanofi-aventis norge (3) - amiodaronhydroklorid - tablett - 200 mg
duodart 0.5 mg / 0.4 mg
glaxosmithkline as - dutasterid / tamsulosinhydroklorid - kapsel, hard - 0.5 mg / 0.4 mg
ketamin abcur 10 mg/ ml
abcur ab - ketaminhydroklorid - injeksjonsvæske, oppløsning - 10 mg/ ml
ketamin abcur 50 mg/ ml
abcur ab - ketaminhydroklorid - injeksjonsvæske, oppløsning - 50 mg/ ml
rimstar
sandoz - københavn - rifampicin / isoniazid / pyrazinamid / etambutolhydroklorid - tablett, filmdrasjert - 150 mg / 75 mg / 400 mg / 275 mg
sixmo
l. molteni & c. dei fratelli alitti società di esercizio s.p.a. - buprenorfin hydrochloride - opioid-relaterte lidelser - andre nervesystemet narkotika - sixmo er indikert for substitusjonsbehandling for opioidavhengighet i klinisk stabil voksne pasienter som ikke krever mer enn 8 mg/dag sublingual buprenorfin, innenfor en ramme av medisinsk, sosial og psykologisk behandling.
amiodaron hameln 50 mg/ ml
hameln pharma gmbh - amiodaronhydroklorid - konsentrat til injeksjons-/infusjonsvæske, oppløsning - 50 mg/ ml
zeposia
bristol-myers squibb pharma eeig - ozanimod hydrochloride - multiple sclerosis, relapsing-remitting; colitis, ulcerative - immunsuppressive - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.
dutasteride/tamsulosin hexal 0.5 mg / 0.4 mg
hexal a/s - dutasterid / tamsulosinhydroklorid - kapsel, hard - 0.5 mg / 0.4 mg
dutasteride/tamsulosin orion 0.5 mg / 0.4 mg
orion corporation - espoo - dutasterid / tamsulosinhydroklorid - kapsel, hard - 0.5 mg / 0.4 mg